home / stock / bvs / bvs news


BVS News and Press, Bioventus Inc. From 03/10/22

Stock Information

Company Name: Bioventus Inc.
Stock Symbol: BVS
Market: NASDAQ
Website: bioventus.com

Menu

BVS BVS Quote BVS Short BVS News BVS Articles BVS Message Board
Get BVS Alerts

News, Short Squeeze, Breakout and More Instantly...

BVS - Bioventus Inc. (BVS) Q4 2021 Earnings Call Transcript

Image source: The Motley Fool. Bioventus Inc. (NASDAQ: BVS) Q4 2021 Earnings Call Mar 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Bioventus Inc. (BVS) Q4 2021 Earnings Call Transcript

BVS - Bioventus Inc. (BVS) CEO Ken Reali on Q4 2021 Results - Earnings Call Transcript

Bioventus Inc. (BVS) Q4 2021 Earnings Conference Call March 10, 2022, 8:30 AM ET Company Participants Ken Reali – Chief Executive Officer Dave Crawford – Vice President of Investor Relations Conference Call Participants Kyle Rose – Canaccord Genuity Drew Ranieri – ...

BVS - Bioventus GAAP EPS of -$0.01 misses by $0.07, revenue of $130.4M in-line; issues FY22 guidance

Bioventus press release (NASDAQ:BVS): Q4 GAAP EPS of -$0.01 misses by $0.07. Revenue of $130.4M (+32.3% Y/Y) in-line. Adjusted EBITDA of $28.5 million, compared to $28.2 million in the prior year. Non-GAAP gross profit was $99.6 million, or 76.3% of net sales, compared to $78.6 million, ...

BVS - Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the fourth quarter and full-year ended December 31, 2021. Fourth Quarter Financi...

BVS - Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

DURHAM, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that the US Food and Drug Administration (FDA) has awarded 510(k) clearance to the next ...

BVS - Bioventus appoints Mark Singleton as CFO

Bioventus (NASDAQ:BVS) has appointed Mark Singleton as the Company’s Senior Vice President, Chief Financial Officer and Principal Accounting Officer, effective March 21, 2022. Most recently, he served as Vice President of Finance, Americas for Teleflex Incorporated,...

BVS - Bioventus Appoints Mark Singleton as Chief Financial Officer

DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has appointed Mark Singleton as the Company’s Senior Vice President,...

BVS - Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter and fiscal year ...

BVS - 3 Healthcare Stocks Trading Near 52-Week Lows to Buy This Month

The healthcare industry is growing rapidly amid increasing demand from an aging population and digital transformation in health systems and technologies, among other factors. And because clinical innovation is expected to continue in the healthcare sector this year, we think it could be profi...

BVS - SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements Fourth Quarter 2021 Financial Results to be Announced in March PR Newswire DALLAS , Feb. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life s...

Previous 10 Next 10